BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33671936)

  • 1. Comparative Analysis of Morphological and Release Profiles in Ocular Implants of Acetazolamide Prepared by Electrospinning.
    Morais M; Coimbra P; Pina ME
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33671936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and Evaluation of Atorvastatin Calcium-Poly-ε-Caprolactone Nanoparticles Loaded Ocular Inserts for Sustained Release and Antiinflammatory Efficacy.
    Girgis GNS
    Curr Pharm Biotechnol; 2020; 21(15):1688-1698. PubMed ID: 32427080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of dexamethasone ophthalmic implants: a comparative study of in vitro release profiles.
    Prata AI; Coimbra P; Pina ME
    Pharm Dev Technol; 2018 Mar; 23(3):218-224. PubMed ID: 28300463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular biocompatibility of dexamethasone acetate loaded poly(ɛ-caprolactone) nanofibers.
    Da Silva GR; Lima TH; Fernandes-Cunha GM; Oréfice RL; Da Silva-Cunha A; Zhao M; Behar-Cohen F
    Eur J Pharm Biopharm; 2019 Sep; 142():20-30. PubMed ID: 31129274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-printed reservoir-type implants containing poly(lactic acid)/poly(caprolactone) porous membranes for sustained drug delivery.
    Korelidou A; Domínguez-Robles J; Magill ER; Eleftheriadou M; Cornelius VA; Donnelly RF; Margariti A; Larrañeta E
    Biomater Adv; 2022 Aug; 139():213024. PubMed ID: 35908473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and in vitro/in vivo evaluation of cyclosporin A-loaded nanodecorated ocular implants for subconjunctival application.
    Pehlivan SB; Yavuz B; Çalamak S; Ulubayram K; Kaffashi A; Vural İ; Çakmak HB; Durgun ME; Denkbaş EB; Ünlü N
    J Pharm Sci; 2015 May; 104(5):1709-20. PubMed ID: 25716582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Star poly(ε-caprolactone)-based electrospun fibers as biocompatible scaffold for doxorubicin with prolonged drug release activity.
    Bala Balakrishnan P; Gardella L; Forouharshad M; Pellegrino T; Monticelli O
    Colloids Surf B Biointerfaces; 2018 Jan; 161():488-496. PubMed ID: 29128835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrospun matrices for localised controlled drug delivery: release of tetracycline hydrochloride from layers of polycaprolactone and poly(ethylene-co-vinyl acetate).
    Alhusein N; Blagbrough IS; De Bank PA
    Drug Deliv Transl Res; 2012 Dec; 2(6):477-88. PubMed ID: 25787326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(caprolactone)-based subcutaneous implant for sustained delivery of levothyroxine.
    Stewart SA; Domínguez-Robles J; Utomo E; Picco CJ; Corduas F; Mancuso E; Amir MN; Bahar MA; Sumarheni S; Donnelly RF; Permana AD; Larrañeta E
    Int J Pharm; 2021 Sep; 607():121011. PubMed ID: 34391850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of intranasal implantable devices for schizophrenia treatment.
    Utomo E; Domínguez-Robles J; Moreno-Castellanos N; Stewart SA; Picco CJ; Anjani QK; Simón JA; Peñuelas I; Donnelly RF; Larrañeta E
    Int J Pharm; 2022 Aug; 624():122061. PubMed ID: 35908633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyester-Polydopamine Copolymers for Intravitreal Drug Delivery: Role of Polydopamine Drug-Binding Properties in Extending Drug Release.
    Bahuon F; Darcos V; Patel S; Marin Z; Coudane J; Schwach G; Nottelet B
    Biomacromolecules; 2022 Oct; 23(10):4388-4400. PubMed ID: 36170117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of drug solubility, state and loading on controlled release in bicomponent electrospun fibers.
    Natu MV; de Sousa HC; Gil MH
    Int J Pharm; 2010 Sep; 397(1-2):50-8. PubMed ID: 20599485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel poly(ε-caprolactone)/gelatin wound dressings prepared by emulsion electrospinning with controlled release capacity of Ketoprofen anti-inflammatory drug.
    Basar AO; Castro S; Torres-Giner S; Lagaron JM; Turkoglu Sasmazel H
    Mater Sci Eng C Mater Biol Appl; 2017 Dec; 81():459-468. PubMed ID: 28887998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidance of glial cell migration and axonal growth on electrospun nanofibers of poly-epsilon-caprolactone and a collagen/poly-epsilon-caprolactone blend.
    Schnell E; Klinkhammer K; Balzer S; Brook G; Klee D; Dalton P; Mey J
    Biomaterials; 2007 Jul; 28(19):3012-25. PubMed ID: 17408736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol-loaded electrospun three-dimensional systems for potential cardiovascular application: Effect of fibers hydrophilization on drug release, and cytocompatibility.
    Rychter M; Milanowski B; Grześkowiak BF; Jarek M; Kempiński M; Coy EL; Borysiak S; Baranowska-Korczyc A; Lulek J
    J Colloid Interface Sci; 2019 Feb; 536():310-327. PubMed ID: 30380431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ofloxacin Loaded Electrospun Fibers for Ocular Drug Delivery: Effect of Formulation Variables on Fiber Morphology and Drug Release.
    Karataş A; Algan AH; Pekel-Bayramgil N; Turhan F; Altanlar N
    Curr Drug Deliv; 2016; 13(3):433-43. PubMed ID: 26521656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core-Shell Polyvinyl Alcohol (PVA) Base Electrospinning Microfibers for Drug Delivery.
    Mares-Bou S; Serrano MA; Gómez-Tejedor JA
    Polymers (Basel); 2023 Mar; 15(6):. PubMed ID: 36987334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Solvent Vapor Annealing on Drug-Loaded Electrospun Polymer Fibers.
    Chiu YJ; Zhang Z; Dziemidowicz K; Nikoletopoulos CG; Angkawinitwong U; Chen JT; Williams GR
    Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32041349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrospun formulations of acyclovir, ciprofloxacin and cyanocobalamin for ocular drug delivery.
    Baskakova A; Awwad S; Jiménez JQ; Gill H; Novikov O; Khaw PT; Brocchini S; Zhilyakova E; Williams GR
    Int J Pharm; 2016 Apr; 502(1-2):208-18. PubMed ID: 26899973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of Molecular Weight, Polymer Concentration and Process Parameters Factors on the Sustained Release of the Anti-Multiple-Sclerosis Agent Teriflunomide from Poly(
    Bikiaris ND; Koumentakou I; Michailidou G; Kostoglou M; Vlachou M; Barmpalexis P; Karavas E; Papageorgiou GZ
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.